BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2493 related articles for article (PubMed ID: 32492712)

  • 1. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
    Al-Samkari H; Karp Leaf RS; Dzik WH; Carlson JCT; Fogerty AE; Waheed A; Goodarzi K; Bendapudi PK; Bornikova L; Gupta S; Leaf DE; Kuter DJ; Rosovsky RP
    Blood; 2020 Jul; 136(4):489-500. PubMed ID: 32492712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis.
    Yu B; Li X; Chen J; Ouyang M; Zhang H; Zhao X; Tang L; Luo Q; Xu M; Yang L; Huang G; Liu X; Tang J
    J Thromb Thrombolysis; 2020 Oct; 50(3):548-557. PubMed ID: 32524516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
    Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
    Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
    Zhang Y; Cao W; Jiang W; Xiao M; Li Y; Tang N; Liu Z; Yan X; Zhao Y; Li T; Zhu T
    J Thromb Thrombolysis; 2020 Oct; 50(3):580-586. PubMed ID: 32648093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and its implications for thrombosis and anticoagulation.
    Connors JM; Levy JH
    Blood; 2020 Jun; 135(23):2033-2040. PubMed ID: 32339221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.
    Thondapu V; Montes D; Rosovsky R; Dua A; McDermott S; Lu MT; Ghoshhajra B; Hoffmann U; Gerhard-Herman MD; Hedgire S
    J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):835-844.e4. PubMed ID: 33188961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.
    Cui S; Chen S; Li X; Liu S; Wang F
    J Thromb Haemost; 2020 Jun; 18(6):1421-1424. PubMed ID: 32271988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
    Voicu S; Delrue M; Chousterman BG; Stépanian A; Bonnin P; Malissin I; Deye N; Neuwirth M; Ketfi C; Mebazaa A; Siguret V; Mégarbane B
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9161-9168. PubMed ID: 32965009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count.
    Bi X; Su Z; Yan H; Du J; Wang J; Chen L; Peng M; Chen S; Shen B; Li J
    Platelets; 2020 Jul; 31(5):674-679. PubMed ID: 32367765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of venous thromboembolism in hospitalized patients with COVID-19.
    Middeldorp S; Coppens M; van Haaps TF; Foppen M; Vlaar AP; Müller MCA; Bouman CCS; Beenen LFM; Kootte RS; Heijmans J; Smits LP; Bonta PI; van Es N
    J Thromb Haemost; 2020 Aug; 18(8):1995-2002. PubMed ID: 32369666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19.
    Berger JS; Kunichoff D; Adhikari S; Ahuja T; Amoroso N; Aphinyanaphongs Y; Cao M; Goldenberg R; Hindenburg A; Horowitz J; Parnia S; Petrilli C; Reynolds H; Simon E; Slater J; Yaghi S; Yuriditsky E; Hochman J; Horwitz LI
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2539-2547. PubMed ID: 32840379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic relationship between D-dimer and COVID-19 severity.
    Li Y; Zhao K; Wei H; Chen W; Wang W; Jia L; Liu Q; Zhang J; Shan T; Peng Z; Liu Y; Yan X
    Br J Haematol; 2020 Jul; 190(1):e24-e27. PubMed ID: 32420615
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study.
    Shah A; Donovan K; McHugh A; Pandey M; Aaron L; Bradbury CA; Stanworth SJ; Alikhan R; Von Kier S; Maher K; Curry N; Shapiro S; Rowland MJ; Thomas M; Mason R; Holland M; Holmes T; Ware M; Gurney S; McKechnie SR
    Crit Care; 2020 Sep; 24(1):561. PubMed ID: 32948243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.
    Elshazli RM; Toraih EA; Elgaml A; El-Mowafy M; El-Mesery M; Amin MN; Hussein MH; Killackey MT; Fawzy MS; Kandil E
    PLoS One; 2020; 15(8):e0238160. PubMed ID: 32822430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.
    Liao D; Zhou F; Luo L; Xu M; Wang H; Xia J; Gao Y; Cai L; Wang Z; Yin P; Wang Y; Tang L; Deng J; Mei H; Hu Y
    Lancet Haematol; 2020 Sep; 7(9):e671-e678. PubMed ID: 32659214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19.
    Rieder M; Goller I; Jeserich M; Baldus N; Pollmeier L; Wirth L; Supady A; Bode C; Busch HJ; Schmid B; Duerschmied D; Gauchel N; Lother A
    J Thromb Thrombolysis; 2020 Oct; 50(3):558-566. PubMed ID: 32617807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation abnormalities and thrombosis in patients with COVID-19.
    Levi M; Thachil J; Iba T; Levy JH
    Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 125.